Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the Isfahan kashani hospital
Background: To manage relapsing-remitting multiple sclerosis (MS) in the course of acute exacerbations, methylprednisolone (MP) (Medrol or Solu-Medrol), has the ability to lock the injured blood-brain barrier and decrease irritation in the central nervous system. The aim of this preliminary study wa...
Main Authors: | Zahra Tolou-Ghamari, Vahid Shaygannejad, Fereshteh Ashtari |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | International Journal of Preventive Medicine |
Subjects: | |
Online Access: | http://www.ijpvmjournal.net/article.asp?issn=2008-7802;year=2013;volume=4;issue=14;spage=274;epage=278;aulast=Tolou-Ghamari |
Similar Items
-
Bradycardia after pulse methylprednisolone therapy in a child—Uncommon side effect of a frequently used drug: A case report
by: Saroj K Tripathy, et al.
Published: (2023-01-01) -
Adverse reaction of methylprednisolone pulse therapy: Acute respiratory distress syndrome
by: Fereshteh Ashtari, et al.
Published: (2021-07-01) -
Methylprednisolone pulse therapy for critically ill patients with COVID-19: a cohort study
by: Keum-Ju Choi, et al.
Published: (2023-02-01) -
The Utility of Intravenous Methylprednisolone as an Adjunct Treatment for Drug-Resistant Amiodarone-Induced Thyrotoxicosis
by: Krzysztof Cezary Lewandowski, et al.
Published: (2024-01-01) -
Pacemakers and methylprednisolone pulse therapy in immune-related myocarditis concomitant with complete heart block
by: Hu Chunhong, et al.
Published: (2022-12-01)